Loss of MTAP expression is frequent in a large number of different human tumors including leukemias, lymphomas, mesothelioma, lung carcinoma, pancreatic carcinoma, squamous cell carcinoma, biliary tract cancer, glioblastoma, osteosarcoma, and neuroendocrine tumors [3]–[15]. Here, MTAP is linked to osteosarcoma.